SCIEX Launches AI-Powered Novus V55 Mass Spectrometry System
MARLBOROUGH, Mass., June 1, 2026 SCIEX, a Danaher company and global leader in life science analytical technologies, has unveiled...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
MARLBOROUGH, Mass., June 1, 2026 SCIEX, a Danaher company and global leader in life science analytical technologies, has unveiled...
